QoL after multimodal treatment of rectal cancer with/without oxaliplatin (phase 3, CAO/ARO/AIO-04)

被引：0
|
作者：
Kosmala, R. [1 ]
Fokas, E. [2 ,3 ]
Flentje, M. [1 ]
Sauer, R. [4 ]
Liersch, T. [5 ]
Graeven, U. [6 ]
Fietkau, R. [4 ]
Hohenberger, W. [7 ]
Arnold, D. [8 ]
Hofheinz, R. [9 ]
Ghadimi, M. [5 ]
Raab, H. [10 ]
Stroebel, P. [11 ]
Staib, L. [12 ]
Grabenbauer, G. G. [13 ]
Folprecht, G. [14 ]
Uter, W. [15 ]
Gall, C. [15 ]
Roedel, C. [2 ,3 ]
Polat, B. [1 ]
机构：
[1] Univ Hosp Wurzburg, Dept Radiat Oncol, Wurzburg, Germany
[2] Goethe Univ Frankfurt, Frankfurt, Germany
[3] German Canc Consortium DKTK Partner Site, Dept Radiotherapy & Oncol, Frankfurt, Germany
[4] Univ Hosp Erlangen, Dept Radiat Oncol, Erlangen, Germany
[5] Univ Med Ctr Gottingen, Dept Gen Visceral & Paediat Surg, Gottingen, Germany
[6] Kliniken Maria Hilf GmbH Monchengladbach, Dept Haematol Oncol & Gastroenterol, Monchengladbach, Germany
[7] Univ Hosp Erlangen, Dept Surg, Erlangen, Germany
[8] Tumour Biol Ctr Freiburg, Freiburg, Germany
[9] Heidelberg Univ, Univ Hosp Mannheim, Interdisciplinary Tumour Ctr, Heidelberg, Germany
[10] Carl von Ossietzky Univ Oldenburg, Dept Gen & Visceral Surg, Oldenburg, Germany
[11] Univ Med Ctr Gottingen, Inst Pathol, Gottingen, Germany
[12] Klinikum Esslingen, Dept Surg, Esslingen, Germany
[13] DiaCura & Klinikum Coburg, Dept Radiat Oncol & Radiotherapy, Coburg, Germany
[14] Univ Hosp Carl Gustav Carus, Univ Canc Ctr, Med Dept 1, Dresden, Germany
[15] Univ Erlangen Nurnberg, Dept Med Informat Biometry & Epidemiol, Erlangen, Germany
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 133卷
关键词：
D O I：
10.1016/S0167-8140(19)30804-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0384
引用
收藏
页码：S191 / S192
页数：2
相关论文
共 50 条
  • [1] Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial
    Kosmala, Rebekka
    Fokas, Emmanouil
    Flentje, Michael
    Sauer, Rolf
    Liersch, Torsten
    Graeven, Ullrich
    Fietkau, Rainer
    Hohenberger, Werner
    Arnold, Dirk
    Hofheinz, Ralf-Dieter
    Ghadimi, Michael
    Stroebel, Philipp
    Staib, Ludger
    Grabenbauer, Gerhard G.
    Folprecht, Gunnar
    Kirste, Simon
    Uter, Wolfgang
    Gall, Christine
    Roedel, Claus
    Polat, Bulent
    EUROPEAN JOURNAL OF CANCER, 2021, 144 : 281 - 290
  • [2] Association of Sex With Toxic Effects, Treatment Adherence, and Oncologic Outcomes in the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trials of Rectal Cancer
    Diefenhardt, Markus
    Ludmir, Ethan B.
    Hofheinz, Ralf-Dieter
    Ghadimi, Michael
    Minsky, Bruce D.
    Roedel, Claus
    Fokas, Emmanouil
    JAMA ONCOLOGY, 2020, 6 (02) : 294 - 296
  • [3] Impact of age on the efficacy of oxaliplatin in the perioperative chemo(radio)therapy of rectal cancer: A post hoc analysis of the CAO/ARO/AIO-04 phase 3 trial
    Hofheinz, R-D
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 123 - 123
  • [4] Tumor Regression Grading in the CAO/ARO/AIO-04 phase 3 trial in locally advanced rectal carcinoma
    Fokas, E.
    Ghadimi, M.
    Fietkau, R.
    Stroebel, P.
    Hartmann, A.
    Sauer, R.
    Liersch, T.
    Hothorn, T.
    Wittekind, C.
    Roedel, C.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S170 - S171
  • [5] NAR score as surrogate for disease-free survival in the CAO/ARO/AIO-04 phase 3 rectal cancer trial
    Fokas, E.
    Fietkau, R.
    Hartmann, A.
    Hohenberger, W.
    Gruetzmann, R.
    Ghadimi, M.
    Liersch, T.
    Stroebel, P.
    Grabenbauer, G.
    Wittekind, C.
    Sauer, R.
    Kaufmann, M.
    Hothorn, T.
    Roedel, C.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S142 - S142
  • [6] Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial
    Jochen Gaedcke
    Malte Sahrhage
    Marcel Ebeling
    Azadeh Azizian
    Felix Rühlmann
    Markus Bernhardt
    Marian Grade
    Wolf Otto Bechstein
    Christoph-Thomas Germer
    Robert Grützmann
    Pompiliu Piso
    Ralf-Dieter Hofheinz
    Ludger Staib
    Tim Beißbarth
    Rebekka Kosmala
    Emmanouil Fokas
    Claus Rödel
    Michael Ghadimi
    Scientific Reports, 15 (1)
  • [7] Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial
    Diefenhardt, Markus
    Martin, Daniel
    Ludmir, Ethan B.
    Fleischmann, Maximilian
    Hofheinz, Ralf-Dieter
    Ghadimi, Michael
    Kosmala, Rebekka
    Polat, Bulent
    Friede, Tim
    Minsky, Bruce D.
    Roedel, Claus
    Fokas, Emmanouil
    CANCERS, 2022, 14 (18)
  • [8] Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO/ARO/AIO-04 phase III trial
    Hofheinz, R. -D.
    Arnold, D.
    Fokas, E.
    Kaufmann, M.
    Hothorn, T.
    Folprecht, G.
    Fietkau, R.
    Hohenberger, W.
    Ghadimi, M.
    Liersch, T.
    Grabenbauer, G. G.
    Sauer, R.
    Roedel, C.
    Graeven, U.
    ANNALS OF ONCOLOGY, 2018, 29 (08) : 1793 - 1799
  • [9] Therapy Adherence as a Key Factor for clinical Outcome in the randomized Phase III CAO/ARO/AIO-04 Rectal Cancer Study
    Diefenhardt, M.
    Ludmir, E. B.
    Hofheinz, R. -D
    Ghadimi, M.
    Minsky, B. D.
    Fokas, E.
    Roedel, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S12 - S12
  • [10] Association of Treatment Adherence With Oncologic Outcomes for Patients With Rectal Cancer A Post Hoc Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial
    Diefenhardt, Markus
    Ludmir, Ethan B.
    Hofheinz, Ralf-Dieter
    Ghadimi, Michael
    Minsky, Bruce D.
    Roedel, Claus
    Fokas, Emmanouil
    JAMA ONCOLOGY, 2020, 6 (09) : 1416 - 1421
12345